0000000000092144

AUTHOR

A. Fontana

showing 10 related works from this author

Age-dependent epileptic encephalopathy associated with an unusual co-occurrence of ZEB2 and SCN1A variants.

2020

Mowat-Wilson syndrome is a genetic disorder associated with a variable phenotype including peculiar facial features associated with intellectual disability, epilepsy, language impairment, and multiple congenital anomalies caused by heterozygous mutation of the ZEB2 gene. The ZEB2 protein is a complex transcription factor that encompasses multiple functional domains that interact with the regulatory regions of target genes including those involved in brain development. Recently, it has been documented that ZEB2 regulates the differentiation of interneuron progenitors migrating from the medial ganglionic eminence to cortical layers by repression of the Nkx2-1 homeobox transcription factor. It…

ZEB2genotype-phenotype correlationSettore MED/38 - Pediatria Generale E SpecialisticaSettore M-PSI/08 - Psicologia ClinicaIntellectual DisabilityHumansMowat-Wilson syndromeEEGgenotype-phenotype correlationSCN1AHirschsprung DiseaseEEGChildGenetic Association StudiesZEB2Zinc Finger E-box Binding Homeobox 2EpilepsyEEG; epilepsy; GABAergic interneurons; genotype-phenotype correlation; Mowat-Wilson syndrome; SCN1A; ZEB2FaciesElectroencephalographySettore MED/39 - Neuropsichiatria InfantileGABAergic interneuronsMowat-Wilson syndromeepilepsyNAV1.1 Voltage-Gated Sodium ChannelGABAergic interneuronsMicrocephalySettore MED/26 - NeurologiaFemaleEpileptic disorders : international epilepsy journal with videotape
researchProduct

Abstracts of the 6th FECS Conference 1998 Lectures.

1998

International audience

[SDU.OCEAN]Sciences of the Universe [physics]/Ocean Atmosphere010504 meteorology & atmospheric sciencesHealth Toxicology and MutagenesisMEDLINE[CHIM.CATA]Chemical Sciences/CatalysisGeneral Medicine010501 environmental sciences01 natural sciencesPollutionEngineering physics[PHYS.COND.CM-MS]Physics [physics]/Condensed Matter [cond-mat]/Materials Science [cond-mat.mtrl-sci]Environmental ChemistryEnvironmental scienceEngineering ethics[PHYS.COND]Physics [physics]/Condensed Matter [cond-mat]ComputingMilieux_MISCELLANEOUS0105 earth and related environmental sciencesEnvironmental science and pollution research international
researchProduct

Organometallic complexes with biological molecules: XII. Solid-state and solution studies on dialkyltin(IV)- and trialkyltin(IV)-thiaminepyrophosphat…

1999

Dialkyltin(IV) and trialkyltin(IV) derivatives of the coenzyme thiaminepyrophosphate (H2TPP) have been synthesized with general formula R2Sn(HTPP)2·nH2O (Alk = Me, n = 2; Alk = Bu, n = 4) and R3SnHTPP·nH2O (R=Me, n = 2; R = Bu, n = 1), respectively. The solid-state structure of the complexes has been investigated through infrared and Mossbauer spectroscopy. The infrared data suggest the involvement of only phosphate oxygen atoms in the coordination of both dialkyl- and trialkyl-tin(IV) moieties, with phosphate anions behaving as monoanionic bidentate bridging or chelating groups, with the tin(IV) involved in six- and five-fold coordination geometries, respectively, in R2Sn(HTPP)2·nH2O (R = …

Inorganic ChemistryDenticityOctahedronChemistryStereochemistryBase pairMössbauer spectroscopyInfrared spectroscopyChelationGeneral ChemistryCarbon-13 NMRHydrateMedicinal chemistryApplied Organometallic Chemistry
researchProduct

Benign Nocturnal Alternating Hemiplegia Of Childhood: A New Case.

2009

Alternating Hemiplegia childhood
researchProduct

SCSA Code: Applications on the Cyclopeptide Renieramide

2004

SCSA is an algorithm designed to get information on molecular conformational properties. The most stable conformers are determined by the homemade SCSA code, performing a multistep systematic conformational search, which involves energy and structure quantum chemical optimizations at low-level and high-level. The SCSA method was employed to analyze the conformational space of the in vacuo cyclopeptide renieramide at AMI and B3LYP/6-31G(d) levels. Calculations at B3LYP level of the GIAO 13C NMR chemical shifts were also performed on the final conformers. In fact, to validate the conformational search results experimental and calculated 13C NMR spectra of renieramide were compared. Slight dis…

researchProduct

RANDOMIZED PHASE II STUDY OF FIRST-LINE EVEROLIMUS (EVE) + BEVACIZUMAB (BEV) VERSUS INTERFERON ALFA-2A (IFN) + BEV IN PATIENTS (PTS) WITH METASTATIC …

2012

ABSTRACT Background Study results demonstrated that IFN augments BEV activity and improves median PFS in pts with mRCC. Thus, combination BEV + IFN is a standard first-line treatment option for mRCC. Combining BEV with the mTOR inhibitor EVE may be an efficacious and well-tolerated treatment option. The open-label, phase II RECORD-2 trial compared first-line EVE + BEV and IFN + BEV in mRCC. Patients and methods: Therapy-naive pts with clear cell mRCC and prior nephrectomy were randomized 1:1 to BEV 10 mg/kg IV every 2 weeks with either EVE 10 mg oral daily or IFN (9 MIU SC 3 times/week, if tolerated). Tumour assessments were every 12 weeks. Primary objective was treatment effect on progress…

medicine.medical_specialtymedicine.medical_treatmentGastroenterology03 medical and health sciences0302 clinical medicineProstateInternal medicinemedicineStomatitisObjective response030304 developmental biology0303 health sciencesProteinuriaGenitourinary systembusiness.industryTreatment optionsHematologymedicine.diseaseNephrectomy3. Good healthmedicine.anatomical_structureOncologyTolerability030220 oncology & carcinogenesismedicine.symptombusinessAnnals of Oncology
researchProduct

Mesonic and Non-Mesonic Weak Decay of Hypernuclei with FINUDA

2009

Abstract The FINUDA experiment performed a systematic study of both mesonic and non-mesonic weak decay of p - shell Λ-hypernuclei. Recent results on the mesonic decay rates and the non-mesonic decay ratios are illustrated and briefly discussed.

PhysicsNuclear and High Energy PhysicsΛ-hypernuclei mesonic decay non-mesonic decay FINUDA experimentHigh Energy Physics::LatticeHigh Energy Physics::PhenomenologyNuclear TheoryΛ-hypernucleiShell (structure)FINUDA experimentweak decaymesonic decayNuclear physicsHypernuclei; weak decayHypernucleinon-mesonic decayHigh Energy Physics::ExperimentNuclear ExperimentFINUDA experiment; mesonic decay; non-mesonic decay; Λ-hypernuclei
researchProduct

The hairy elbows syndrome: clinical and neuroradiological findings.

2009

The hairy elbows syndrome (HES) is a rare congenital phenotype characterized by an abnormal increase in long hairs localized on the upper limbs extensor surfaces. This feature is often associated with short stature, facial asymmetry, dysmorphisms, intrauterine growth retardation (IUGR), and mental and speech delay. We report a case with hypertricosis cubiti associated with infantile spasms, behaviour disorders and cerebral hemisphere asymmetry. Although these findings have not been previously described we are uncertain whether they are unusual or underestimated. However, it is likely that these neurological findings are strongly interrelated leading to a more severe phenotype of the syndrom…

MaleSpasmSettore MED/38 - Pediatria Generale E SpecialisticaChild PreschoolElbowHypertrichosisBrainHumansSyndromeEPILESSIA EEGSettore MED/39 - Neuropsichiatria Infantile
researchProduct

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study

2019

Abstract Metronomic chemotherapy (mCHT) refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen, with no prolonged drug-free breaks, that leads to antitumor activity. Aim of the present study is to describe the use of mCHT in a retrospective cohort of metastatic breast cancer (MBC) patients in order to collect data regarding the different types and regimens of drugs employed, their efficacy and safety. Between January 2011 and December 2016, data of 584 metastatic breast cancer patients treated with mCHT were collected. The use of VRL-based regimens increased during the time of observation (2011: 16.8% - 2016: 29.8%), as well as CTX-bas…

AdultOncologymedicine.medical_specialtyCyclophosphamideSettore MED/06 - Oncologia MedicaAntineoplastic AgentsBreast NeoplasmsVinorelbineDrug Administration ScheduleAntineoplastic AgentEfficacyCapecitabine03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerRetrospective StudieInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumans030212 general & internal medicineProgression-free survivalCyclophosphamideRetrospective StudiesAgedAged 80 and overAntineoplastic Combined Chemotherapy Protocolbusiness.industryMetronomic chemotherapyVinorelbineGeneral MedicineMiddle Agedmedicine.diseaseMetastatic breast cancerMetronomic ChemotherapySurvival RateMethotrexateTreatment Outcome030220 oncology & carcinogenesisMED/06 - ONCOLOGIA MEDICAFemaleSurgerybusinessBreast NeoplasmHumanmedicine.drugThe Breast
researchProduct

New results on mesonic weak decay of p-shell Lambda-hypernuclei

2009

The FINUDA experiment performed a systematic study of the charged mesonic weak decay channel of $p$-shell $\Lambda$-hypernuclei. Negatively charged pion spectra from mesonic decay were measured with magnetic analysis for the first time for ${^{7}_{\Lambda}Li}$, ${^{9}_{\Lambda}Be}$, ${^{11}_{\Lambda}B}$ and ${^{15}_{\Lambda}N}$. The shape of the $\pi^{-}$ spectra was interpreted through a comparison with pion distorted wave calculations that take into account the structure of both hypernucleus and daughter nucleus. Branching ratios $\Gamma_{\pi^{-}}/\Gamma_{tot}$ were derived from the measured spectra and converted to $\pi^{-}$ decay rates $\Gamma_{\pi^{-}}$ by means of known or extrapolate…

PhysicsGround-state spin assignmentNuclear and High Energy Physicsp-Shell Lambda-hypernuclei; Mesonic decayNuclear Theorylambda hypernuclei; mesonic decaylambda hypernucleiHypernucleusMesonic decaySpectral linemesonic decayPionmedicine.anatomical_structurep-Shell Lambda-hypernucleimedicineHigh Energy Physics::Experimentp-Shell Λ-hypernucleiAtomic physicsMagnetic analysisNuclear ExperimentNuclear ExperimentNucleus
researchProduct